Patel; Jatin M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Patel; Jatin M..The latest application filed is for "bilayer tablet formulations".
- Patel; Jatin M. - Princeton NJ
- Patel; Jatin M. - New Brunswick NJ
- Patel, Jatin M. - West Windsor NJ
- Patel; Jatin M. - Lawrenceville NJ
| Patent | Date |
|---|---|
| Bilayer Tablet Formulations App 20170333353 - Abebe; Admassu ; et al. | 2017-11-23 |
| Bilayer tablet formulations Grant 9,616,028 - Abebe , et al. April 11, 2 | 2017-04-11 |
| Pharmaceutical formulations containing an SGLT2 inhibitor Grant 9,198,925 - Bindra , et al. December 1, 2 | 2015-12-01 |
| Bilayer Tablet Formulations App 20150238421 - Abebe; Admassu ; et al. | 2015-08-27 |
| Bilayer tablet formulations Grant 9,050,258 - Abebe , et al. June 9, 2 | 2015-06-09 |
| Reduced Mass Metformin Formulations App 20140335170 - Abebe; Admassu ; et al. | 2014-11-13 |
| Pharmaceutical Formulations Containing An Sglt2 Inhibitor App 20140243262 - Bindra; Dilbir S. ; et al. | 2014-08-28 |
| Pharmaceutical formulations containing an SGLT2 inhibitor Grant 8,716,251 - Bindra , et al. May 6, 2 | 2014-05-06 |
| Bilayer Tablet Formulations App 20130330406 - Abebe; Admassu ; et al. | 2013-12-12 |
| Bilayer tablet formulations Grant 8,535,715 - Abebe , et al. September 17, 2 | 2013-09-17 |
| Pharmaceutical Formulations Containing An SGLT2 Inhibitor App 20130129819 - Bindra; Dilbir S. ; et al. | 2013-05-23 |
| Pharmaceutical formulations containing an SGLT2 inhibitor Grant 8,361,972 - Bindra , et al. January 29, 2 | 2013-01-29 |
| Reduced Mass Metformin Formulations App 20120294936 - Abebe; Admassu ; et al. | 2012-11-22 |
| Bilayer Tablet Formulations App 20120282336 - Abebe; Admassu ; et al. | 2012-11-08 |
| Pharmaceutical Formulations Containing an SGLT2 Inhibitor App 20120263786 - Bindra; Dilbir S. ; et al. | 2012-10-18 |
| Pharmaceutical formulations containing an SGLT2 inhibitor Grant 8,221,786 - Bindra , et al. July 17, 2 | 2012-07-17 |
| Pharmaceutical Formulations Containing an SGLT2 Inhibitor App 20110064801 - Bindra; Dilbir S. ; et al. | 2011-03-17 |
| Pharmaceutical formulations containing an SGLT2 inhibitor Grant 7,851,502 - Bindra , et al. December 14, 2 | 2010-12-14 |
| Pharmaceutical Formulation Containing An Sglt2 Inhibitor App 20080234366 - Bindra; Dilbir S. ; et al. | 2008-09-25 |
| Modified-release vasopeptidase inhibitor formulation, combinations and method App 20040005358 - Slugg, Peter H. ; et al. | 2004-01-08 |
| Salt form of nefazodone for use in extended release formulations Grant 6,034,085 - Joshi , et al. March 7, 2 | 2000-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 